SYNOPSIS Liver biopsies from 97 hepatitis B antigen (HB%Ag)-positive patients were stained by a modified orcein method described by Shikata et al (1974) Although more than 10 years have elapsed since the discovery of hepatitis B antigen (HBsAg) (Blumberg, 1964) , its localization in tissues has hitherto remained a complicated procedure, requiring immunofluorescence or electron microscopy. Recently, however, Shikata, Uzava, Yoshiwara, Akatsuka, and Yamazaki (1974) have developed simple histochemical methods for the demonstration of HB.Ag in conventional paraffin sections. The mechanism is apparently based on the presence of disulphide bonds in HBsAg (Vyas, Rao, and Ibrahim, 1972a; Sukeno, Shirachi, Yamaguchi, and Ishida, 1972) . This paper reports the results of staining by one method described by Shikata et al (1974) in liver biopsies from patients with acute and chronic liver disease and from asymptomatic carriers of the antigen.
modified orcein method described by Shikata et al (1974) in order to detect the antigen in liver tissue. The results were consistently negative in acute hepatitis, but positive in nearly two-thirds of biopsies from 53 patients with chronic liver disease. The distribution of positive staining was frequently irregular so that there is a problem of sampling error in needle biopsies. The deposits were seen in the cytoplasm of liver cells and occasionally in Kupffer cells, but never in nuclei. There was an inverse relationship between staining and parenchymal necrosis. Biopsies from asymptomatic HB8Ag carriers were often strongly positive, as were 'ground-glass' hepatocytes in carriers and patients with chronic liver disease. The mechanism of staining is unclear but may be related to the presence of disulphide bonds in HB8Ag. The technique is simple and of use both in fresh and stored material.
Although more than 10 years have elapsed since the discovery of hepatitis B antigen (HBsAg) (Blumberg, 1964) , its localization in tissues has hitherto remained a complicated procedure, requiring immunofluorescence or electron microscopy. Recently, however, Shikata, Uzava, Yoshiwara, Akatsuka, and Yamazaki (1974) have developed simple histochemical methods for the demonstration of HB.Ag in conventional paraffin sections. The mechanism is apparently based on the presence of disulphide bonds in HBsAg (Vyas, Rao, and Ibrahim, 1972a; Sukeno, Shirachi, Yamaguchi, and Ishida, 1972) . This paper reports the results of staining by one method described by Shikata et al (1974) All slides were stained by a modification of the orcein stain for elastic tissue (Shikata et al, 1974 In all biopsies the orcein-positive material was present in the cytoplasm of some of the liver cells. Nuclear staining was never seen. In seven biopsies positive material was also seen in a few Kupffer cells; six of these biopsies were from patients with chronic liver disease and one was from a symptomless carrier.
In some biopsies large areas of negative staining were seen adjacent to positive areas (fig 3) (1973) . Five of these biopsies were from asymptomatic carriers of the antigen (fig 4) . In one carrier with biliary obstruction subsequently shown to be due to carcinoma of the pancreas, the presence of 'ground-glass' cells supported the view that the patient's jaundice was not due to acute hepatitis. 'Ground-glass' liver cells were never found in orcein-negative biopsies, and were seen to be orcein-positive (fig 1) .
RESULTS IN PATIENTS WITH MULTIPLE BIOPSIES
Thirteen follow-up liver biopsies were available for study from 11 patients. Of the 10 patients in whom only one additional biopsy was performed, seven remained orcein-positive. Two were both seronegative and orcein-negative and the third orcein-negative patient had active cirrhosis with much necrosis. One patient with active cirrhosis was biopsied on four occasions and orcein-positive cells were seen in only one biopsy showing relatively mild liver damage.
Discussion
The original observation by Shikata et al (1974) that some cells in the livers of patients with chronic liver diseases stained with the elastic Van Gieson stain was made accidentally. These authors then suggested that the apparent affinity of HBsAg to dyes such as Alcian blue and Gomori's aldehyde fuchsin was due to the presence of disulphide bonds, since the antigen has been shown to have high levels of cystine (Dreesman, Hollinger, Suriano, Fujioka, Brunschwig, and Melnick, 1972; Vyas, Williams, Klaus and Bond, 1972b) . It is believed that disulphide bonds play an important role in antigenicity and particle size of HBsAg (Sukeno et al, 1972; Vyas et al, 1972a) . The orcein stain also has an affinity for other structures rich in disulphide bonds, such as the keratin of the hair follicles. More direct evidence that it is the antigen that is stained with orcein is the close correspondence found between positive staining and specific immunofluorescence for HBsAg (Shikata et al, 1974; Gerber, Vernace, and Popper, 1974) . In three of our orcein-positive biopsies the presence of HBsAg in hepatocytes was confirmed by electron microscopy.
In our study the orcein method was consistently negative in acute hepatitis, but useful for detecting the antigen in a variety of chronic liver diseases. Even in orcein-positive biopsies, the staining was confined to areas showing little or no necrosis, in keeping with the findings of Krawczynski, Nazarewicz, Brzosko, and Nowoslawski (1972) (1974) in that the latter obtained 100% positive results in a group of patients including 'Au-positive hepatitis', but the proportion of patients with acute disease was not specified. Our lower positive results could perhaps be explained by sampling error, since the orcein-positive cells have been shown to be irregularly distributed within biopsies. However, it seems more likely that our consistently negative results in acute hepatitis, even in large biopsies, reflect genuine absence, paucity, or lack of staining of the antigen. This is consistent with the findings of Dudley, Fox, and Sherlock (1971) of an inverse relationship between the degree of liver cell damage and the titre of circulating antigen. However, Tapp, Jones, Anfield, Whittaker, Woolf, and Dymock (1974) found no such relationship in their patients. Hadziyannis, Vissoulis, Moussouros, and Afroudakis (1972) observed that the number of fluorescent liver cells and the intensity of fluorescence was much more in normal liver of carriers than in the damaged liver of patients with chronic hepatitis and cirrhosis. Moreover, Krawczynski et al (1972) failed to detect the antigen in nine biopsies from patients with fulminant hepatitis.
Sixteen of the 41 orcein-positive biopsies, including five from HBsAg carriers, contained typical 'groundglass' hepatocytes, as described by Hadziyannis et al (1973) . These authors observed the cells in 18 of 19 biopsies from carriers and suggested that their presence in an otherwise normal liver should lead to a suspicion of the antigen carrier state. The results of orcein staining in our series tend to confirm the conclusion based on immunofluorescent studies (Deutsch and Spence, 1972; Nielsen, Nielsen, and Elling, 1973) and it thus seems possible that in the carrier state infection has resulted in abundant formation of viral coat, but not core, without leading to cytopathogenic effects. The orcein stain seems to reveal coat rather than core antigen. This may explain our consistently negative results in acute hepatitis and the inverse relationship with parenchymal necrosis.
In conclusion, we believe that the method devised by Shikata et al (1974) shows HB5Ag in the tissues. False negative results in chronic liver disease are most likely to be due to sampling error. The method should not be used for primary detection of HB5Ag in patients; its value lies in the possibility of studying the localization of the antigen at a cellular level, and above all the opportunity to study stored material obtained from patients before its discovery. We have seen orcein-positive material in a liver biopsy stored since 1963. Finally, the method has been used by us in differentiating acute hepatitis from the carrier state in an acutely jaundiced patient.
